MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to immunitybio...
-$351,398K
(15.03%↑ Y/Y)
Net loss
attributable to...
-$74K
(8.64%↑ Y/Y)
Net loss
-$351,472K
(15.03%↑ Y/Y)
Income tax benefit
-$135K
Loss before income
taxes and...
-$351,607K
(15.00%↑ Y/Y)
Product
$112,982K
(698.46%↑ Y/Y)
Product And Service
Other
$306K
(-48.57%↓ Y/Y)
Loss from operations
-$256,027K
(25.61%↑ Y/Y)
Total other expense,
net
-$95,580K
(-37.60%↓ Y/Y)
Total revenue
$113,288K
(668.31%↑ Y/Y)
Change in fair value of
warrant liabilities
-$49,089K
(-146.00%↓ Y/Y)
Interest and investment
income, net
$6,405K
(-19.69%↓ Y/Y)
Change in fair value of
derivative liabilities
$6,398K
(-52.53%↓ Y/Y)
Total operating costs
and expenses
$369,315K
(2.89%↑ Y/Y)
Interest
expense-Related Party
$60,886K
Interest expense related
to revenue...
$51,540K
(29.96%↑ Y/Y)
Change in fair value of
related-party convertible...
-$42,773K
Other expense, net
-$2,174K
(-14393.33%↓ Y/Y)
Interest
expense-Nonrelated Party
$99K
Research and
development-Nonrelated Party
$207,875K
Selling, general and
administrative-Nonrelated Party
$147,180K
Research and
development-Related Party
$10,684K
Selling, general and
administrative-Related Party
$2,823K
Cost of sales
$753K
Back
Back
Income Statement
source: myfinsight.com
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)